Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models
Supreet Agarwal(University of Iowa), Kathleen Kelly(National Cancer Institute)
Cited by 28
Related Papers
Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma
|PLoS ONE|2013|34
The origin and dynamics of cellular heterogeneity vary across lineage subtypes of castrate resistant prostate cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3